参考文献： [1]Chinese Phmxnaceutical Association.Report on Advances in Phar-macy 2010-2011 [M].Beijing: China Science and'1'echnology Press,2011:4 [2]X1A0 Y H,G1SKL,C G,WEI Z Q,et al.L,pidemiology and char-acteTistics of antimicrobial resistance in China [J].Drug Resist Updates,2011,14(4-5):236-250 [3]LIANG H,TENG F,JI A G.Multi-drug resistant Gram-negative bacteria and polymyxins [J].Chin PharnaJ,2012,47(24:2049-2051. [4]TALBOT G H,BRADLEY J,EDWARDS J E,et al.Bad bugs need drugs:An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America [J]Clin Irpfect Dis,2006,42 (5):657-668 [5]LI Y,LU Y,XUE F,et al.Antimicrobial susceptibility surveilance in China:A MOIINARIN program report(2009-2010)[J]China」Lab Med,2012,35(1):88-92参考文献: [1] Chinese Phmxnaceutical Association. Report on Advances in Phar-macy 2010-2011 [M] .Beijing: China Science and'1'echnology Press,2011 :4 [2] X1A0 Y H, G1SKL, C G, WEI Z Q, et al. L,pidemiology and char-acteTistics of antimicrobial resistance in China [J].Drug Resist Updates, 2011,14 (4-5):236-250 [3] LIANG H, TENG F,JI A G. Multi-drug resistant Gram-negative bacteria and polymyxins [J] . Chin Pharna J,2012,47(24):2049-2051. [4] TALBOT G H,BRADLEY J, EDWARDS J E,et al.Bad bugs need drugs:An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America [J]Clin lrpfect Dis, 2006, 42 (5):657-668 [5] Ll Y,LU Y, XUE F, et al. Antimicrobial susceptibility surveilance in China: A MOIINARIN program report(2009-2010) [J]ChinaJ Lab Med,2012, 35 (1) :88-92